Provided by Tiger Trade Technology Pte. Ltd.

Axsome Therapeutics

207.77
-0.2600-0.12%
Post-market: 207.770.00000.00%19:30 EDT
Volume:734.95K
Turnover:153.13M
Market Cap:10.88B
PE:-55.13
High:210.87
Open:207.22
Low:206.50
Close:208.03
52wk High:260.19
52wk Low:112.90
Shares:52.38M
Float Shares:43.83M
Volume Ratio:1.37
T/O Rate:1.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7685
EPS(LYR):-3.6821
ROE:-245.10%
ROA:-16.31%
PB:130.64
PE(LYR):-56.43

Loading ...

Stock Track | Axsome Therapeutics Soars 5.03% Intraday on Strong Q1 Revenue Growth, FDA Approval and Analyst Upgrades

Stock Track
·
May 04

Strong Drug Sales Lift Axsome Revenue, But Profit Miss Drags Stock

Benzinga Earnings
·
May 04

Deutsche Bank Adjusts Axsome Therapeutics PT to $281 From $245, Maintains Buy Rating

MT Newswires Live
·
May 04

Axsome Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
May 04

Axsome Therapeutics Q1 revenue rises 57%, but loss widens on rising costs

Reuters
·
May 04

Axsome Q1 FY26 net loss widens to $64.5 million; revenue rises 57% to $191.2 million

Reuters
·
May 04

Earnings Flash (AXSM) Axsome Therapeutics Posts Q1 Loss $1.26 a Share, vs. FactSet Est of $0.86 Loss

MT Newswires Live
·
May 04

Axsome Therapeutics Q1 EPS $(1.26) Misses $(0.90) Estimate, Sales $191.203M Beat $189.193M Estimate

Benzinga Earnings
·
May 04

BRIEF-Axsome Therapeutics Q1 Net Income USD -64.542 Million

Reuters
·
May 04

Axsome Therapeutics Q1 EPS USD -1.26

THOMSON REUTERS
·
May 04

Axsome Therapeutics Q1 Pretax Profit USD -64.542 Million

THOMSON REUTERS
·
May 04

Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update

GlobeNewswire
·
May 04

Axsome Therapeutics price target raised to $270 from $250 at H.C. Wainwright

TIPRANKS
·
May 04

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
May 04

U.S. Earnings Preview: Before Market Open May 4

Dow Jones
·
May 04

U.S. RESEARCH ROUNDUP- Alphabet, Colgate-Palmolive, Welltower

Reuters
·
May 04

Axsome Therapeutics (AXSM) Is Up 11.1% After FDA Clears AUVELITY For Alzheimer’s Agitation Treatment

Simply Wall St.
·
May 04

Axsome Therapeutics Is Maintained at Buy by Needham

Dow Jones
·
May 02

Axsome Therapeutics price target raised to $255 from $215 at TD Cowen

TIPRANKS
·
May 01

Axsome Therapeutics Inc : TD Cowen Raises Target Price to $255 From $215

THOMSON REUTERS
·
May 01